Study of ALXN1101 in Neonates With Molybdenum Cofactor Deficiency (MOCD) Type A
Condition: Molybdenum Cofactor Deficiency, Type AIntervention: Drug: ALXN1101Sponsor: Alexion Pharma GmbHNot yet recruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2015 Category: Research Source Type: clinical trials